In Situ Hybridization Market: probe-based technology and products is anticipated to boost the growth

In Situ Hybridization Industry Overview

The global in situ hybridization market size was valued at USD 1,333.5 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.9% from 2021 to 2028. Increasing prevalence of target disorders, increasing investments in in-vitro diagnostics space, and technological advancements in in situ hybridization (ISH) are some key driving factors for market growth.

The COVID-19 pandemic also served as a driving factor for the ISH market growth. In June 2021, The University of Oxford collaborated with the University of Warwick to research a method to detect the COVID-19 virus in 20 minutes using in situ hybridization. This technology is previously used to detect pathogens inside cells, such as the Epstein-Barr and HIV. Such developments are expected to propel market growth in the near future.

Gather more insights about the market drivers, restrains and growth of the Global In Situ Hybridization market

In the past few years, various research institutions and organizations have indulged in thorough R&D for developing a technology to determine the molecular profiles of single cells. For instance, Bio-protocol developed in situ hybridization technique known as Proximity Ligation in situ Hybridization. The technique is considered high performance, low cost, rapid multiplexing, and simple to use.

The affordable in situ hybridization technology increases the accessibility for developing countries, which are highly prone to infections and diseases. Regulatory bodies have launched various policies and initiatives to increase awareness among people. For instance, in August 2021, Federal Capital Territory Public Health Department in Nigeria collaborated with the WHO to spread awareness of infectious diseases.

In recent years, the use of ISH products has expanded, leading to an increasing, number of specialized contract research organizations. This intensified the market competition. For instance, with rigorous legislative requirements and high sample throughput, Reveal Biosciences serves research on tissue and advanced tissue technology services using in situ hybridization and other methods.

Browse through Grand View Research’s Biotechnology Industry Research Reports.

• Cancer Biomarker Market – The global cancer biomarker market size was valued at USD 10.3 billion in the year 2016 and is estimated to reach a value of USD 33.7 billion by 2025, growing with CAGR of 14.3 %. Growing prevalence of malignancies coupled with increasing focus on development of targeted therapies is a major factor affirming the positive growth of this market.
  
  
• Pharmaceutical Filtration Market – The global pharmaceutical filtration market size was estimated at USD 13.7 billion in 2016 and is expected to witness lucrative growth during the forecast period. Increasing emphasis on biologics and their development for the treatment of various diseases is a major attribute expected to trigger growth.

In Situ Hybridization Market Segmentation

Grand View Research has segmented the global in situ hybridization market based on technology type, probe, product, application, end-use, and region:

 In Situ Hybridization Technology Outlook (Revenue, USD Million, 2017 – 2028)

• Fluorescent In Situ Hybridization (FISH)
• Chromogenic In Situ Hybridization (CISH)

In Situ Hybridization Probe Type Outlook (Revenue, USD Million, 2017 – 2028)

• DNA
• RNA

In Situ Hybridization Product Outlook (Revenue, USD Million, 2017 – 2028)

• Instruments
• Kits and Probes
• Software
• Services

In Situ Hybridization Application Outlook (Revenue, USD Million, 2017 – 2028)

• Cancer
• Cytogenetics
• Developmental Biology
• Infectious Diseases
• Others

In Situ Hybridization End-use Outlook (Revenue, USD Million, 2017 – 2028)

• Hospitals & Diagnostic Laboratories
• Contract Research Organizations (CROs)
• Academic & Research Institutions
• Others

In Situ Hybridization Regional Outlook (Revenue, USD Million, 2017 – 2028)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Market Share Insights

• April 2021: Applied Spectral Imaging and Kromatid signed a strategic partnership agreement to be the exclusive seller of Kromatid’sPinpoint fluorescence in situ hybridization (PPF) probes and assay services.

Key Companies profiled:

Some prominent players in the global In Situ Hybridization market include

• Leica Biosystems Nussloch GmbH
• Merck KGaA
• Thermo Fisher Scientific
• Agilent Technologies
• BIO VIEW
• PerkinElmer, Inc.
• NeoGenomics Laboratories, Inc.
• Bio-Rad Laboratories, Inc.
• Oxford Gene Technology
• Advanced Cell Diagnostics, Inc.

Order a free sample PDF of the In Situ Hybridization Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter